SRTS Sensus Total Debt to Capital

SRTS (Sensus Healthcare Corp) - company brandmark

Sensus Healthcare, Inc. (SRTS) is recognized as a leader in non-invasive therapy for skin neoplasms, offering safe outpatient solutions. Due to its focus on the domestic US market, the business is shielded from geopolitical risks, and the market trend visualized in monetary format on GURU.Markets shows a total debt-to-equity ratio of 0.01. Patents for emitters and FDA certification ensure a high barrier to entry.

Sensus Healthcare - SRTS Debt to Capital (period 07/04/2022 - 10/28/2026)

Comprehensive metric breakdowns and analytics for Sensus (SRTS)

- price and consensus price forecast:
Stock Quotes Sensus Healthcare|SRTS - Analyst Forecast Prices
- market capitalization data:
Market Capitalization Sensus Healthcare|SRTS - Value Adjusted for Debt and Cash
- book capitalization data:
Book Value per Share Sensus Healthcare|SRTS - Total Stockholders' Equity|Market Value to Book Value Ratio sensushealthcare.com|SRTS - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Sensus Healthcare, Inc.|SRTS - Long-Term Debt to Capital|Short-Term Debt to Equity Sensus Healthcare, Inc.|SRTS - Company Aggregate Indebtedness|Debts to Book Capitalization Sensus Healthcare|SRTS - Long-Term Debt|Company Current Liabilities Sensus Healthcare
Basic company analysis:Sensus Healthcare SRTS
Finished products of Sensus Healthcare, Inc.

A comparative analysis of this ratio allows investors to evaluate the deleveraging strategy by weighing total credit obligations against equity to determine the degree of financial autonomy. Stable cash flows from service maintenance and consumables within the Sensus Healthcare, Inc. (SRTS) ecosystem minimize over-leverage risks, which is reflected in the trend of the total liabilities-to-equity ratio.

Analysis of competing companies

Dexcom (DXCM) - Total Debt to Equity Ratio|Aggregate Debt to Capital Penumbra Inc|Novanta Corp (NOVT) - Total Debt to Capital|All Debt to Shareholders' Equity Ratio Haemonetics Company (HAE)|INSP: Total Debt to Capital|procept-biorobotics.com - Debt to Capital|Debt to Equity CONMED (CNMD)|PLSE - All Debt to Shareholders' Equity Ratio|INMD: Total Debt to Capital|PMI (Picard Group) - Total Debt to Capital|Debt to Equity Surmodics, Inc. SRDX|Aggregate Debt to Equity Senseonics Corp|NeuroPace - Total Debt to Capital|Debt to Capital tactilemedical.com TCMD|Total Debt to Equity Ratio SNWV (SANUWAVE Health, Inc.)|OM - Total Debt to Capital|Total Debt to Equity Ratio Electromed Inc ELMD|LNSR - Aggregate Debt to Capital|AVITA Medical - Total Debt to Capital|Profound Medical (PROF) - Total Debt to Capital Coefficient|Total Debt to Capital BDMD|Total Debt to Equity Ratio EDAP Medical (EDAP)|Apyx Medical (APYX) - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio ICCM (icecure-medical.com)|Pulmonx - Debt to Equity|Total Debt to Equity Ratio TELA Bio Inc. TELA|CTSO (CytoSorbents Corp.) - Total Debt to Capital|ZYXI - Debt to Capital|Total Debt to Capital electrocore.com|Vicarious Surgical (RBOT) - Debt to Equity Ratio|IINN: Total Debt to Capital|Total Debt to Capital Coefficient SeaStar Medical Holding Corporation|Total Debt to Capital IRIX (IRIDEX Corporation)|Total Debt to Equity Ratio ibs.inc (INBS)|Total Debt to Capital XAIR (Beyond Air)|profusa.com - Total Debt to Capital|SSKN - Debt to Equity|glucotrack.com (GCTK) - Debt to Equity|Total Debt to Equity Ratio NanoVibronix NAOV|Venus Concept Corporation (VERO) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital NUWE (Nuwellis, Inc.)|Debt to Capital AEMD|ASXC: Debt to Equity|Debt to Capital Ratio Avinger Inc. AVGR|Total Debt to Equity Ratio BSGM (BioSig Technologies, Inc.)|Total Debt to Capital Cutera Inc CUTR|Total Debt to Capital KNW (Know Labs, Inc.)|NARI: Total Debt to Capital Coefficient|Debt to Equity Nevro (NVRO)|RSLS (ReShape Lifesciences Inc.) - Aggregate Debt to Equity|Debt to Equity SILK